Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort

Abstract

Late Epstein-Barr virus infection and hypovitaminosis-D as environmental risk factors in the pathogenesis of multiple sclerosis are gaining great interest. We, therefore, tested for in-vivo interdependence between Epstein-Barr-virus (EBV)-status and 25-hydroxyvitamin D3 (25(OH)D3) -level in healthy young individuals from a United Kingdom (UK) autumn cohort. EBV-load was measured by quantitative polymerase chain reaction and 25(OH)D3 levels by isotope-dilution liquid chromatography-tandem mass spectrometry. This young, healthy UK autumn cohort showed surprisingly low levels of 25(OH)D3 (mean value: 40.5 nmol/L ± 5.02). Furthermore, we found that low 25(OH)D3 levels did not impact on EBV load and anti-EBV nuclear antigen-1 (EBNA-1) titers. However, we observed a correlation between EBV load and EBNA-1 titers. These observations should be of value in the study of the potential relationship between hypovitaminosis-D and EBV-status in the pathophysiology of multiple sclerosis.

Keywords

environment immunology infection

Get full access to this article

View all access options for this article.

References

Ramagopalan

Dobson

Meier

. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 2010; 9: 727–739.

Meier

Giovannoni

Tzartos

. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system? Clin Exp Immunol 2012; 167: 1–6.

Ascherio

Munger

Lunemann

. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012; 8: 602–612.

Tzartos

Khan

Vossenkamper

. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology 2012; 78: 15–23.

Munger

Levin

Hollis

. Serum 25-Hydroxyvitamin D levels and risk of Multiple Sclerosis. JAMA 2006; 296: 2832–2838.

Holick

Binkley

Bischoff-Ferrari

. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 2011; 96: 1911–1930.

Ramagopalan

Heger

Berlanga

. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20: 1352–1360.

Yenamandra

Hellman

Kempkes

. Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell Mol Life Sci : CMLS 2010; 67: 4249–4256.

Gallagher

Armstrong

MacKenzie

. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin’s disease. Int J Cancer 1999; 84: 442–448.

10.

Disanto

Handel

Damoiseaux

. Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients. Mult Scler 2013; July 4 [Epub ahead of print].

11.

Laaksi

Ruohola

J-P

Tuohimaa

. An association of serum vitamin D concentration < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007; 86: 714–717.